Magazine Article | June 1, 2023

Key Questions To Ask When Entering A Pharma Partnership

Source: Life Science Leader

By Jody Staggs

Rising interest rates have created challenges for life sciences companies seeking funding. The cost of equity or venture debt has increased dramatically since 2021, and for some biotech companies is not available at any price. For these companies, non-dilutive funding via a strategic partner can be a compelling alternative, although it carries risks.

Before entering a partnership, executives need to ask themselves and their prospective partners’ key questions in the following five areas:


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader